NDUFS4

NDUFS4 Full Name

NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)

NDUFS4 Introduction

NDUFS4 encodes the 18 kDa iron-sulfur protein subunit of mitochondrial complex I, an accessory component that is notable both for its location at the catalytic core of the enzyme and for the regulatory phosphorylation it undergoes. The subunit sits on the matrix side of complex I, within the peripheral arm that contains the iron-sulfur clusters through which electrons travel from NADH toward ubiquinone, and it contributes to the organization of this electron-transfer machinery. A distinctive feature of NDUFS4 is its phosphorylation by the mitochondrial isoform of protein kinase A, which provides a mechanism through which cAMP signaling can acutely stimulate complex I activity; dephosphorylation by mitochondrial phosphatases reverses this effect. This regulatory layer is believed to couple the activity of the respiratory chain to the energy demands and hormonal status of the cell. Mutations in NDUFS4 are among the best-characterized genetic causes of Leigh syndrome, a devastating early-onset neurodegenerative disorder caused by defects in mitochondrial energy metabolism. The Ndufs4 knockout mouse reproduces the cardinal features of Leigh syndrome and has become the most widely used animal model for studying the pathogenesis of this disease and for testing therapeutic interventions, giving NDUFS4 an importance far beyond its small size.

Figure 1. NDUFS4 gene:from mitochondria to leigh syndrome.

Iron-Sulfur Subunit Localization and cAMP-Dependent Regulation
The NDUFS4 gene is located on human chromosome 5, and its product is a hydrophilic protein of approximately 18 kDa that is imported into the mitochondrial matrix after synthesis in the cytoplasm.
Within the assembled enzyme, NDUFS4 is positioned on the matrix arm of complex I, near the iron-sulfur cluster relays that conduct electrons from the flavin site to ubiquinone.
Although it does not itself coordinate an iron-sulfur cluster, the subunit stabilizes the arrangement of neighboring cluster-binding proteins and is required for the efficient assembly and full activity of the complex.
The C-terminal region of NDUFS4 contains the site of phosphorylation by protein kinase A, and the mitochondrial cAMP-PKA pathway regulates complex I activity through this phosphorylation.
This regulatory connection allows extracellular signals that raise cAMP to enhance mitochondrial respiration, linking cellular signaling to the rate of oxidative phosphorylation.
Loss of NDUFS4, whether through mutation or knockdown, impairs the assembly of complex I and causes a selective deficiency of its activity without grossly affecting the other respiratory chain complexes.
The ability to phosphorylate NDUFS4 is conserved in mammals, underscoring the physiological importance of the cAMP-dependent regulation of complex I.

Leigh Syndrome, the Ndufs4 Mouse Model, and Therapeutic Frontiers
Mutations in NDUFS4 cause Leigh syndrome, a progressive encephalopathy of infancy or childhood characterized by bilateral brain lesions, psychomotor regression, seizures, and respiratory dysfunction, typically leading to early death.
The biochemical hallmark of the disorder is a severe deficiency of complex I activity in affected tissues, most notably the brain, where energy failure drives the pathological changes.
Ndufs4 knockout mice develop a progressive neurological syndrome with brainstem lesions, gliosis, and metabolic disturbances that closely mirror human Leigh syndrome, providing a faithful platform for mechanistic studies.
Because the mouse model recapitulates the human disease, it has been used to test candidate therapies including rapamycin, gene therapy, and agents that modulate metabolism, several of which have shown encouraging effects on survival.
The phosphorylation of NDUFS4 has also made it a focus of research into how mitochondrial signaling pathways intersect with disease, since chronic activation or loss of the cAMP-PKA axis may influence the severity of mitochondrial dysfunction.
Studies of NDUFS4 thus connect the detailed biochemistry of complex I assembly and regulation to one of the most important mitochondrial diseases of childhood and to the broader search for therapies that can slow or reverse neurodegeneration.

Alternate Names for NDUFS4

NDUFS4; NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe S protein 4 (18kD) (NADH coenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial; AQDQ; CI 18; complex I 18kDa subunit; CI-AQDQ; CI-18 kDa; complex I-AQDQ